The study of sleep medicine & breathing disorders continues to uncover complex interrelations between respiratory physiology and sleep architecture. Obstructive sleep apnea, central sleep apnea, and nocturnal hypoventilation syndromes are now understood as contributors to cardiovascular disease, metabolic dysfunction, and neurocognitive impairment. CPAP and bilevel therapies remain foundational, but new research is exploring alternative treatments like hypoglossal nerve stimulation and positional therapies. With wearable sleep diagnostics and remote polysomnography gaining traction, personalized care is increasingly achievable. Sleep Medicine & Breathing Disorders is also contributing to public health policy by linking sleep-related breathing issues to occupational performance, road safety, and mental well-being. Emerging tools like machine learning for apnea detection and circadian rhythm profiling offer new frontiers for individualized intervention. Clinicians are now urged to adopt a multidisciplinary lens, integrating pulmonology, neurology, and behavioral medicine in sleep health management.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation